Shanghai Runda Medical Technology Co., Ltd.

XSSC:603108 Stock Report

Market Cap: CN¥11.1b

Shanghai Runda Medical Technology Past Earnings Performance

Past criteria checks 1/6

Shanghai Runda Medical Technology's earnings have been declining at an average annual rate of -4.2%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 7.3% per year. Shanghai Runda Medical Technology's return on equity is 3.1%, and it has net margins of 0.5%.

Key information

-4.2%

Earnings growth rate

-4.1%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate7.3%
Return on equity3.1%
Net Margin0.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shanghai Runda Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSSC:603108 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 248,433401,518125
30 Jun 248,7611901,516138
31 Mar 249,0422151,546144
31 Dec 239,1472731,511147
30 Sep 239,7513951,728149
30 Jun 2310,2554331,790153
31 Mar 2310,5044571,764147
31 Dec 2210,4944181,776146
30 Sep 229,8543651,512141
30 Jun 229,3783361,402130
31 Mar 229,0083321,371127
31 Dec 218,8603801,295123
30 Sep 218,7844161,325113
30 Jun 218,3694221,264105
31 Mar 217,7903881,16699
31 Dec 207,0693301,06687
30 Sep 206,7842531,01678
30 Jun 206,70024698969
31 Mar 206,82027398965
31 Dec 197,05231099559
30 Sep 196,82131194755
30 Jun 196,46429287254
31 Mar 196,20027386846
31 Dec 185,96426283544
30 Sep 185,72929579534
30 Jun 185,35126775747
31 Mar 184,85524270941
31 Dec 174,31921967733
30 Sep 173,64219957027
30 Jun 173,0291645400
31 Mar 172,5161344530
31 Dec 162,1651163910
30 Sep 161,9481153150
30 Jun 161,8121053010
31 Mar 161,721952790
31 Dec 151,629922680
30 Sep 151,528922390
30 Jun 151,483842260
31 Mar 151,420812160
31 Dec 141,359752050
31 Dec 131,026681570

Quality Earnings: 603108 has high quality earnings.

Growing Profit Margin: 603108's current net profit margins (0.5%) are lower than last year (4.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 603108's earnings have declined by 4.2% per year over the past 5 years.

Accelerating Growth: 603108's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 603108 had negative earnings growth (-89.8%) over the past year, making it difficult to compare to the Life Sciences industry average (-14.4%).

Return on Equity

High ROE: 603108's Return on Equity (3.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:35
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Runda Medical Technology Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin ZhangChina International Capital Corporation Limited
Xiao Wei LinEverbright Securities Co. Ltd.
Lin YangHaitong International Research Limited